Cialis Use Tied to Higher Glaucoma Risk in New Study
A newly published large-scale study has drawn attention in the vision community for reporting an association between tadalafil — the medication sold under the brand name Cialis — and a higher risk of developing open-angle glaucoma. The findings, based on real-world patient data, add to a growing but still unsettled conversation about whether erectile-dysfunction drugs that inhibit PDE5 may influence eye health over the long term.
Researchers have long hypothesized a plausible biological pathway. PDE5 inhibitors relax smooth muscle and dilate blood vessels, which can alter ocular blood flow and, in some cases, transiently affect intraocular pressure. Because glaucoma is a progressive optic-nerve condition often tied to pressure and blood supply, any drug that perturbs these dynamics deserves scrutiny. However, the new study is observational, meaning it can show correlation but cannot prove that tadalafil directly causes glaucoma. Confounding factors — such as age, metabolic health, and other medications — may play a role in the apparent link.
What This Means for Vision Patients
For individuals already diagnosed with glaucoma or those at elevated risk, the study reinforces the value of a coordinated care approach. Anyone taking tadalafil who notices vision changes, eye pain, or unusual pressure sensations should raise these symptoms with a clinician promptly. Conversely, patients who are considering the medication should not interpret this single report as a definitive warning, but rather as a reason to have an informed conversation about their personal risk profile.
This article is for educational purposes only and does not constitute medical advice. Because glaucoma can develop silently, routine comprehensive eye exams remain the most reliable way to detect it early. Readers with questions about tadalafil and their eye health should consult an eye-care professional, who can weigh the benefits of the medication against any potential ocular risks in the context of their full medical history.